Occult Follicular Carcinoma of Thyroid Presenting as Skull Bone Metastasis: A Rare Case Report
DOI:
https://doi.org/10.37591/rrjooh.v7i3.549Abstract
Follicular thyroid carcinoma (FTC) is a well-differentiated tumor and second most common cancer of the thyroid after papillary carcinoma. They account for 5 to 15% of primary thyroid cancers. Most patient present with a thyroid swelling, only up to 11% patient present with distant metastasis. Skull is a rare site for metastasis. The incidence of skull metastasis of FTC is about 2.5% and, in most cases, metastasis occurred after the diagnosis and treatment of primary tumor; but in few cases, skull metastasis was the first presentation of an occult FTC. We report a case of a 63-year-old female presenting with a headache for 6 months and swelling in right parietal vertex region for 1 month. Neuroimaging showed calvarium based intradiploic extradural lytic expansile lesion, which on histopathology showed the features of metastatic follicular carcinoma from thyroid, which was confirmed by Immunohistochemistry (TTF-1). Thyroid examination and thyroid function tests were normal. Subsequent workup revealed an occult primary follicular carcinoma in the thyroid.
Keywords: Skull metastasis, occult primary, follicular thyroid carcinoma (FTC), TTF-1
Cite this Article
Pramila Choudhary, S.R. Negi, Meeta Deval et al. Occult Follicular Carcinoma of Thyroid Presenting as Skull Bone Metastasis: A Rare Case Report. Research & Reviews: Journal of Oncology and Hematology. 2018; 7(3): 30–33p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |